We shouldn’t take fright at the prospect of an aspirin a day

 

Share

It is the pill for almost every ill. We have known for well over a decade that aspirin prevented some types of cancer (and may even help treat them) as well as diabetes, dementia, pregnancy complications and, of course, pain. It is the most versatile drug in the pharmacy.

So why are we not all taking it? Because scientists have been uncertain whether its benefits outweighed its drawbacks. Aspirin irritates the gut lining – causing, in some people, bleeding and peptic ulcers. Rarely, this can be fatal.

Today’s study from Cancer Research UK appears to resolve the dilemma. Aspirin cuts deaths from at least three common cancers by up to half – a sizeable gain – while the risk of a life-threatening stomach bleed is “very low”. As the lead researcher, Professor Jack Cuzick, put it at today’s press conference: “It is a good bet.”

Within hours, however, Cancer Research UK was rowing back from this position. Dr Julie Sharp, its head of health information, warned that “important questions need to be answered” before it could be recommended, including what was the best dose, how long it should be taken and what test to use to determine who is likely to suffer side effects.

Back to square one, then. The only beneficiaries from the latest study look likely to be other scientists in search of research grants.

Is Cancer Research UK fearful of being seen to promote the medicalisation of society? The row over statins – recommended by Nice for millions more adults last month – has stirred anxieties that we are seeking medical fixes for unhealthy lifestyles. Of course, we should stop smoking, eat better and exercise more. But is prescribing a daily statin or aspirin qualitatively different from vaccinating healthy people?

It depends what you think medicine is for – treating the sick or keeping people healthy. The answer should be: both.

React Now

Latest stories from i100
iJobs Job Widget
iJobs General

Ashdown Group: Front-End UI Application Developer

£30000 - £40000 per annum + Benefits: Ashdown Group: Front-End UI Application ...

Recruitment Genius: Digital Account Executive

£18000 - £26000 per annum: Recruitment Genius: They work with major vehicle ma...

Recruitment Genius: Service Engineers - Doncaster / Hull

£27000 per annum: Recruitment Genius: Domestic Service Only Engineers are requ...

Recruitment Genius: Employability / Recruitment Adviser

£23600 - £27500 per annum: Recruitment Genius: The Employability Service withi...

Day In a Page

Read Next
 

Errors & Omissions: how to spell BBQ and other linguistic irregularities

John Rentoul
 

South Africa's race problem is less between black and white than between poor blacks and immigrants from sub-Saharan Africa

John Carlin
Where the spooks get their coffee fix: The busiest Starbucks in the US is also the most secretive

The secret CIA Starbucks

The coffee shop is deep inside the agency's forested Virginia compound
Revealed: How the Establishment closed ranks over fallout from Loch Ness Monster 'sighting'

How the Establishment closed ranks over fallout from Nessie 'sighting'

The Natural History Museum's chief scientist was dismissed for declaring he had found the monster
One million Britons using food banks, according to Trussell Trust

One million Britons using food banks

Huge surge in number of families dependent on emergency food aid
Excavation at Italian cafe to fix rising damp unearths 2,500 years of history in 3,000 amazing objects

2,500 years of history in 3,000 amazing objects

Excavation at Italian cafe to fix rising damp unearths trove
The Hubble Space Telescope's amazing journey, 25 years on

The Hubble Space Telescope's amazing journey 25 years on

The space telescope was seen as a costly flop on its first release
Did Conservative peer Lord Ashcroft quit the House of Lords to become a non-dom?

Did Lord Ashcroft quit the House of Lords to become a non-dom?

A document seen by The Independent shows that a week after he resigned from the Lords he sold 350,000 shares in an American company - netting him $11.2m
Apple's ethnic emojis are being used to make racist comments on social media

Ethnic emojis used in racist comments

They were intended to promote harmony, but have achieved the opposite
Sir Kenneth Branagh interview: 'My bones are in the theatre'

Sir Kenneth Branagh: 'My bones are in the theatre'

The actor-turned-director’s new company will stage five plays from October – including works by Shakespeare and John Osborne
The sloth is now the face (and furry body) of three big advertising campaigns

The sloth is the face of three ad campaigns

Priya Elan discovers why slow and sleepy wins the race for brands in need of a new image
How to run a restaurant: As two newbies discovered, there's more to it than good food

How to run a restaurant

As two newbies discovered, there's more to it than good food
Record Store Day: Remembering an era when buying and selling discs were labours of love

Record Store Day: The vinyl countdown

For Lois Pryce, working in a record shop was a dream job - until the bean counters ruined it
Usher, Mary J Blige and Will.i.am to give free concert as part of the Global Poverty Project

Mary J Blige and Will.i.am to give free concert

The concert in Washington is part of the Global Citizen project, which aims to encourage young people to donate to charity
10 best tote bags

Accessorise with a stylish shopper this spring: 10 best tote bags

We find carriers with room for all your essentials (and a bit more)
Paul Scholes column: I hear Manchester City are closing on Pep Guardiola for next summer – but I'd also love to see Jürgen Klopp managing in England

Paul Scholes column

I hear Manchester City are closing on Pep Guardiola for next summer – but I'd also love to see Jürgen Klopp managing in England
Jessica Ennis-Hill: 'I just want to give it my best shot'

Jessica Ennis-Hill: 'I just want to give it my best shot'

The heptathlete has gone from the toast of the nation to being a sleep-deprived mum - but she’s ready to compete again. She just doesn't know how well she'll do...